Ignite Creation Date:
2024-05-06 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 2:32 PM
Study NCT ID:
NCT05363267
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2022-04-26
Brief Title:
NF-1 Nutraceutical Intervention
Sponsor:
Masonic Cancer Center University of Minnesota
Organization:
Masonic Cancer Center University of Minnesota
Study Overview
Official Title:
Study of Nutraceutical Intervention With High Phenolic Extra Virgin Olive Oil and Curcumin for Neurofibromatosis Type 1 NF1
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The treatment plan is identical for all participants with the exception of the curcumin dose level that is assigned at study enrollment Participants are instructed to take the curcumin and olive oil one after the other order does not matter twice a day on an empty stomach ideally 30 minutes before breakfast and dinner
Curcumin and high phenolic extra virgin olive oil HP-EVOO may continue for up to 12 months in the absence of unacceptable side effects
Curcumin and high phenolic extra virgin olive oil HP-EVOO may continue for up to 12 months in the absence of unacceptable side effects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None